# 144 - References

# References

Schizophrenia and related psychoses
CHAPTER 1
References
1. Barton BB, et al. Update on weight-­gain caused by antipsychotics: a systematic review and meta-­analysis. Expert Opin Drug Saf 2020; 
19:295–314.
2. Correll CU, et al. Antipsychotic drugs and obesity. Trends Mol Med 2011; 17:97–107.
3. Stogios N, et al. Antipsychotic-­induced weight gain in severe mental illness: risk factors and special considerations. Curr Psychiatry Reps 
2023; 25:707–721.
4. Cuerda C, et al. The effects of second-­generation antipsychotics on food intake, resting energy expenditure and physical activity. Eur J Clin 
Nutr 2014; 68:146–152.
5. Nielsen MO, et al. Striatal reward activity and antipsychotic-­associated weight change in patients with schizophrenia undergoing initial treatment. JAMA Psychiatry 2016; 73:121–128.
6. Ragguett RM, et al. Association between antipsychotic treatment and leptin levels across multiple psychiatric populations: an updated meta-­
analysis. Hum Psychopharmacol 2017; 32:e2631.
7. Reynolds GP, et  al. Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment. 
J Psychopharmacol 2017; 31:1430–1436.
8. Kanji S, et al. The microbiome–gut–brain axis: implications for schizophrenia and antipsychotic induced weight gain. Eur Arch Psychiatry 
Clin Neurosci 2018; 268:3–15.
9. Qian L, et al. Longitudinal gut microbiota dysbiosis underlies olanzapine-­induced weight gain. Microbiol Spectr 2023; 11:e0005823.
10. Fang X, et al. The role of the gut microbiome in weight-­gain in schizophrenia patients treated with atypical antipsychotics: evidence based 
on altered composition and function in a cross-­sectional study. Psychiatry Res 2023; 328:115463.
11. Ye W, et al. Mechanism and treatments of antipsychotic-­induced weight gain. Int J Obes (Lond) 2023; 47:423–433.
12. Garcia-­Rizo C. Antipsychotic-­induced weight gain and clinical improvement: a psychiatric paradox. Front Psychiatry 2020; 11:560006.
13. Smith ECC, et al. Clinical improvement in schizophrenia during antipsychotic treatment in relation to changes in glucose parameters: a systematic review. Psychiatry Res 2023; 328:115472.
14. Hermes E, et al. The association between weight change and symptom reduction in the CATIE schizophrenia trial. Schizophr Res 2011; 
128:166–170.
15. Zhang JP, et al. Pharmacogenetic associations of antipsychotic drug-­related weight gain: a systematic review and meta-­analysis. Schizophr 
Bull 2016; 42:1418–1437.
16. Bak M, et al. Almost all antipsychotics result in weight gain: a meta-­analysis. PLoS One 2014; 9:e94112.
17. McEvoy JP, et al. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, 
double-­blind 52-­week comparison. Am J Psychiatry 2007; 164:1050–1060.
18. Vochoskova K, et al. Weight and metabolic changes in early psychosis—association with daily quantification of medication exposure during 
the first hospitalization. Acta Psychiatr Scand 2023; 148:265–276.
19. Seeman MV. Secondary effects of antipsychotics: women at greater risk than men. Schizophr Bull 2009; 35:937–948.
20. Stamoula E, et al. Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database 
(FAERS). Expert Opin Drug Saf 2024; 23:239–245.
21. Cooper SJ, et al. BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis 
and antipsychotic drug treatment. J Psychopharmacol 2016; 30:717–748.
22. Sabé M, et al. Comparative effects of 11 antipsychotics on weight gain and metabolic function in patients with acute schizophrenia: a dose-­
response meta-­analysis. J Clin Psychiatry 2023; 84:22r14490.
23. Leucht S, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-­treatments meta-­analysis. Lancet 
2013; 382:951–962.
24. Leucht S, et al. Sixty years of placebo-­controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-­analysis, 
and meta-­regression of efficacy predictors. Am J Psychiatry 2017; 174:927–942.
25. Musil R, et al. Weight gain and antipsychotics: a drug safety review. Expert Opin Drug Saf 2015; 14:73–96.
26. Pillinger T, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic 
dysregulation, and association with psychopathology: a systematic review and network meta-­analysis. Lancet Psychiatry 2020; 7:64–77.
27. Vázquez-­Bourgon J, et al. Pattern of long-­term weight and metabolic changes after a first episode of psychosis: results from a 10-­year prospective follow-­up of the PAFIP program for early intervention in psychosis cohort. Eur Psychiatry 2022; 65:e48.
28. Chua YC, et al. A retrospective database study on 2-­year weight trajectories in first-­episode psychosis. Front Psychiatry 2023; 14:1185874.
29. Wu H, et al. Antipsychotic-­induced weight gain: dose-­response meta-­analysis of randomized controlled trials. Schizophr Bull 2022; 48:643–654.
30. Speyer H, et al. Reversibility of antipsychotic-­induced weight gain: a systematic review and meta-­analysis. Front Endocrinol (Lausanne) 
2021; 12:577919.